期刊
JOURNAL OF NEUROSCIENCE METHODS
卷 199, 期 2, 页码 249-257出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneumeth.2011.05.020
关键词
Parkinson's disease; Amyloid; Protein aggregation; alpha-Synuclein; ELISA; Secretion
资金
- Ministry of Education, Science and Technology [2010-0015188, 2010-0020610]
- Korean Government [KRF-2007-331-C00214, 2009-0073566]
- National Research Foundation of Korea [2009-0073566] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Abnormal intracellular deposition of aggregated alpha-synuclein is the characteristic feature of a number of neurological disorders, including Parkinson's disease (PD). Although alpha-synuclein is typically known as a cytosolic protein, a small amount is secreted by exocytosis in both monomeric and aggregated forms. The extracellular forms of alpha-synuclein in human body fluids, such as cerebrospinal fluid (CSF) and blood plasma, might be a diagnostic target for PD and related diseases. Here, we characterized a new set of monoclonal antibodies against alpha-synuclein, and using different combinations of antibodies, we established ELISA systems to specifically detect human alpha-synuclein, mouse and human alpha-synuclein together, and multimeric forms of alpha-synuclein in biological samples. By employing the Tyramide signal amplification method, the sensitivity of the assay was significantly improved to detect a concentration as low as similar to 12.5 pg/ml. These assays might be useful tools for quantitative analysis of alpha-synuclein in various forms and with high sensitivity in diverse biological samples. (C) 2011 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据